Theragen Biologics Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
- Paid Up Capital ₹ 6.14 Cr
- Company Age 17 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -97.26%
- Profit Growth -16.99%
- Ebitda -16.23%
- Net Worth 0.16%
- Total Assets 56.41%
About Theragen Biologics
Theragen Biologics Private Limited (TBPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 2008 and has a history of 17 years. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as K.R. Powergen Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 6.14 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arumugam Sivaraman, Andal Arumugam, and Chaniyilparampu Ramchand serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100TN2008PTC066189
-
Company No.
066189
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jan 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Theragen Biologics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arumugam Sivaraman
|
Director | 25-Jan-2008 | Current |
|
Andal Arumugam
|
Director | 25-Jan-2008 | Current |
Chaniyilparampu Ramchand
|
Director | 02-May-2018 | Current |
Financial Performance of Theragen Biologics.
Theragen Biologics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 97.26% decrease. The company also saw a substantial fall in profitability, with a 16.99% decrease in profit. The company's net worth moved up by a moderate rise of 0.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Theragen Biologics?
In 2022, Theragen Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sri Ramachandra Sports Sciences Private LimitedArumugam Sivaraman and Andal Arumugam are mutual person
-
Axon Constructions Private LimitedArumugam Sivaraman is a mutual person
-
Maggenome Technologies Private LimitedArumugam Sivaraman and Chaniyilparampu Ramchand are mutual person
-
Tcp LimitedChaniyilparampu Ramchand is a mutual person
-
Bbp Studio Virtual Bharat Private LimitedArumugam Sivaraman is a mutual person
-
R.K.Powergen Private LimitedArumugam Sivaraman and Andal Arumugam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Theragen Biologics?
Theragen Biologics has a workforce of 23 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Theragen Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theragen Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
